Abstract
A prospective double-blind controlled study was performed on the effects of isoprinosine in 81 patients with clinical and histological features of classical acute viral hepatitis. Appetite was assessed daily. Serum alanine aminotransferase, aspartic aminotransferase, and bilirubin levels were assessed weekly. Changes in biochemical parameters, number of deaths, number of patients showing rise of aminotransferase levels despite treatment, and duration required for appetite to return to normal in each group were compared. Observation was continued for 4 weeks. Contrary to preliminary reports, no therapeutic benefit was demonstrated in any of these parameters. We concluded that isoprinosine was ineffective in the acute phase of classical acute viral hepatitis.
Similar content being viewed by others
References
Muldoon RL, Mezny L, Jackson GG: Effect of isoprinosine against influenza and some other viruses causing respiratory diseases. Antimicrob Agents Chemother 2:224–228, 1972
Chang TW, Weinstein L: Antiviral activity of isoprinosinein vitro andin vivo. Am J Med Sci 265:143–146, 1973
Gordon P, Ronsen B, Brown ER: Anti-herpes virus action of isoprinosine. Antimicrob Agents Chemother 5:153–160, 1974
Sternberg TH, Macotela Ruiz E: Tratamiento del herpez zoster y herpes simplex con Isoprinosina. Prensa Med Mex 37:159–160, 1972
Stefano JC, Scarpiello V, Genoves M, Antonini G, Ink J, Ink de Vila N: Algunas virosis eruptivas y el NPT 10381 como tratamiento. Orient Med (Argentina) XX, 950:342, 1971
Ink J, Andres FJ, Antonini GM, Scarpiello V, Stefano JC; NPT 10381 agente antiviroso: estudio clinico y bioestadistico. Prensa Med Argent 57:2050–2061, 1971
Streletz LJ, Cracco J: The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE). Ann Neurol 1:183–184, 1977
Dainko EA: NPT 10381 in viral hepatitis: A preliminary report. 11th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chalfonte-Hadden Hall Hotel, Atlantic City, New Jersey, October 1971
Lao LM, Alora BD, Tiu JB, Balatico F: Infectious hepatitis: A comparative study of therapeutic methods. Philip J Microb Infect Dis 11:1–13, 1973
Mosley JW, Galambos J: Viral hepatitis. Diseases of the Liver, 4th ed L. Schiff (ed) Philadelphia, Lippincott 1975, pp 500–593
Boyer JL, Klatskin G: Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). N Engl J Med 283:1063–1071, 1970
Mistilis SP: Chronic active hepatitis. Diseases of the Liver, 4th ed. L. Schiff (ed.). Philadelphia, Lippincott 1975, pp 787–814.
Demetriou JA, Drewes PA, Gin JB: Enzymes. Clinical Chemistry, Principles and Technics, 2nd ed. RJ Henry, DC Cannon, JW Winkelman (eds). New York, Harper & Row, 1974, pp 815–1002.
Morgenstern S, Oklander M, Auerbach J, Kaufman J, Klein B: Automated determination of serum glutamic oxaloacetic transaminase. Clin Chem 12:95–111, 1966
Jendrassik L, Grof P: Vereinfachte photometrische Methoden zur Bestimmung des Blutbilirubins. Biochem Z 297:81–89, 1938
Mosley JW: The epidemiology of viral hepatitis: An overview. Am J Med Sci 270:253–270, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lam, K.C., Lin, H.J., Lai, C.L. et al. Isoprinosine in classical acute viral hepatitis. Digest Dis Sci 23, 893–896 (1978). https://doi.org/10.1007/BF01072462
Issue Date:
DOI: https://doi.org/10.1007/BF01072462